McDonnell Boehnen Hulbert & Berghoff LLP will be offering a live webinar entitled "The Continued Influence of PTAB Proceedings on Bio/Pharma Patents" on September 18, 2018 from 10:00 am to 11:15 am (CT). In this presentation, MBHB attorneys Alison J. Baldwin and Paula S. Fritsch will discuss the following topics:
• A review of how bio/pharma patents have fared before the PTAB;
• An analysis of how PTAB proceedings are impacting ANDA and biosimilar litigations;
• A discussion of how the Supreme Court's recent SAS decision is impacting PTAB invalidity proceedings in the bio/pharma space;
• A discussion of how the PTAB's proposed rulemaking regarding the claim construction standard could impact bio/pharma patents; and
• A discussion regarding potential legislative action to alter the impact of PTAB proceedings on ANDA litigation.
While there is no fee to participate, attendees must register in advance. Those wishing to register can do so here. CLE credit is pending for the states of California, Illinois, New Jersey, New York, North Carolina, and Virginia.
Is there an updated status on the CLE credit for this webinar?
Posted by: Erin Thomson | September 17, 2018 at 10:40 AM
Erin:
Please contact Joe Milligan at [email protected] with any questions you may have regarding the availability of CLE for this webinar.
And thank you for reading Patent Docs.
Don
Posted by: Donald Zuhn | September 17, 2018 at 11:22 AM